Overview
This is a research study to look at blood sugar changes during chemotherapy using a continuous blood sugar monitoring device. The device uses patches that attach to the skin on the back of the arm to measure blood sugar changes for the duration of the chemotherapy course. Each patch lasts for about 2-weeks. During chemotherapy visits, new patches will be placed and will be worn until the chemotherapy course is complete. Participants will be in this study for 6 months. Approximately 50 patients will be enrolled in this study.
Eligibility
Inclusion Criteria:
- Age 18 years
- History of stage I-III breast cancer
- Patient scheduled to receive adjuvant or neoadjuvant chemotherapy
- Signed informed consent
Exclusion Criteria:
- Current treatment with insulin
- Current treatment with non-topical steroids, with the exception of steroid treatment as a supportive chemotherapy medication
- Inability to provide informed consent